Перевести на Переведено сервисом «Яндекс.Перевод»

Neogenomics

Страна
USA
Краткое название
Neogenomics
Штаб квартира
12701 Common Wealth Drive Suite 9
Члены правления

Douglas M. VanOort,
Chairman of the Board of Directors and Chief Executive Officer
Maher Albitar, M.D.,
Chief Medical Officer and Director of Research and Development
Robert Gasparini, M.S., CLSp(CG), CLDir,
Chief Scientific Officer, Board Member
George A. Cardoza,
Chief Financial Officer
Steven C. Jones,
Executive Vice President Finance, Chief Compliance Officer, Board Member
Robert H. Horel,
Vice President of Sales and Marketing

Разделы медицины
Онкология
Стадия проекта
Производство
Заболевания
Рак крови, Рак щитовидной железы и др.эндокринных желез, Рак мужских половых органов, Рак женских половых органов, Рак молочной железы, Рак легкого, Рак кишечника, Рак желудка
Тикер
NEO
Текущие владельцы

Douglas M. VanOort,
Chairman of the Board of Directors and Chief Executive Officer
Robert P. Gasparini, M.S., CLSp(CG), CLDir,
Chief Scientific Officer, Board Member
Steven C. Jones,
Executive Vice President Finance, Chief Compliance Officer, Board Member
Michael T. Dent M.D.,
Board Member
Kevin C. Johnson,
Board Member
Raymond R. Hipp,
Board Member
William J. Robison,
Board Member

Объем фонда
332.6300
Технологии
Клеточные технологии, Технологии, Фармацевтика, Химия